Andreas Blum

3PUBLICATIONS
16CO-AUTHORS
Molecular targetsGene and molecular therapyCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 28, 2025
M4205 (IDRX-42) Is a Highly Selective and Potent Inhibitor of Relevant Oncogenic Driver and Resistance Variants of KIT in Cancer.

Christina Esdar, Nina Linde, Andreas Blum

|Feb 02, 2023
Identification of M4205─A Highly Selective Inhibitor of KIT Mutations for Treatment of Unresectable Metastatic or Recurrent Gastrointestinal Stromal Tumors.

Andreas Blum, Dieter Dorsch, Nina Linde

|Dec 14, 2022
MSC-1186, a Highly Selective Pan-SRPK Inhibitor Based on an Exceptionally Decorated Benzimidazole-Pyrimidine Core.

Martin Schröder, Matthias Leiendecker, Ulrich Grädler

Pageof 1

Frequent Collaborators

1 joint publications

Martin Schröder

1 joint publications

Benedict-Tilman Berger

1 joint publications

Stefan Knapp

1 joint publications

Timo Heinrich